EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 37 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,000 | -70.0% | 1,288 | -60.2% | 0.00% | -100.0% |
| Q4 2015 | $10,000 | -44.4% | 3,235 | -21.5% | 0.00% | 0.0% |
| Q3 2015 | $18,000 | +500.0% | 4,121 | +1137.5% | 0.00% | – |
| Q1 2015 | $3,000 | +200.0% | 333 | +126.5% | 0.00% | – |
| Q4 2014 | $1,000 | -50.0% | 147 | -30.0% | 0.00% | – |
| Q3 2014 | $2,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|